It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
Otherwise healthy people who catch swine flu should not be given Tamiflu, the World Health Organisation (WHO) said.
The advice contradicts British policy on the issue - which has seen hundreds of thousands of doses of the antiviral given to people with the virus.
The latest WHO advice, from a panel of international experts, comes as new figures show that 45,986 courses of antivirals were given to patients in England in the week ending August 18.
In the previous week, 90,363 courses of antivirals were given out.
This data relates to people collecting the drugs after an assessment vi
Oseltamivir (INN) (pronounced /ɒsəlˈtæmɨvɪr/) is an antiviral drug that slows the spread of non-resistant strains of the influenza virus between cells in the body. It is used in the treatment and prophylaxis of Influenzavirus A and Influenzavirus B infection. Like zanamivir, oseltamivir is a neuraminidase inhibitor. It acts as a transition-state analogue inhibitor of influenza neuraminidase, preventing progeny virions from detaching from infected cells. Oseltamivir was the first orally active neuraminidase inhibitor commercially developed. It is a prodrug, which is hydrolysed hepatically to the active metabolite, the free carboxylate of oseltamivir (GS4071). It was developed by US-based Gilead Sciences and is currently marketed by Hoffmann–La Roche (Roche) under the trade name Tamiflu. In Japan, it is marketed by Chugai Pharmaceutical Co., which is more than 50% owned by Roche. Oseltamivir is generally available by prescription only.[1]
The first swine flu vaccines are likely to be licensed for use in the general population in September, the World Health Organization has announced.
Update, 3 July, 16:48 : Japan and Hong Kong have also reported finding Tamiflu-resistant H1N1 viruses. The Japanese virus, like the Danish case, was from a patient receiving prophylactic Tamiflu, but the Hong Kong virus was sampled June 11 from a girl travelling from the US who was not known to have taken the drug.
Originally posted by getreadyalready
reply to post by TrainDispatcher
It is an "anti-viral" it shortens the duration of the flu and tempers the symptoms somewhat. If you are not able to take it within the first 3 days, then it has absolutely no benefits.